Gardasil HPV Vaccine Trial Using Infants as Young as One Year of AgeFor years I have said the goal was to add Gardasil to the infant (vaccine) schedule. It appears that's where we are headed. Sales of the Gardasil vaccine are slumping, as this has never been a popular vaccine due to the dangerous side-effects. In spite of the fact that HPV is a sexually transmitted disease, and that the vaccine wears off long before an infant is sexually active, it appears that drug company lobbyists and the CDC will successfully add the Gardasil HPV vaccine to the infant vaccine schedule. It's not unbelievable and it's not over the top for the CDC to do this. They've done this before. They did it with the Hepatitis B vaccine. Hepatitis B vaccine was initially introduced and targeted at-risk adults, including those who engaged in promiscuous sex (heterosexual and homosexual) and IV drug users. Other "at-risk" populations included hospital workers (due to potential exposure to infected blood and body fluids) and people who were incarcerated or institutionalized. The problem was, just as has happened with Gardasil, they couldn't get the numbers up. They couldn't get enough adults to take the vaccine (Hep B), so they added it to the infant schedule, because that's when they could "get everyone."
Gardasil HPV Vaccine Trial Using Infants as Young as One Year of Age
The HPV vaccine is given in muscle tissue. From there it will cause a blood borne immune response. This response makes antibodies, proteins that attach themselves to another specific protein. Gardasil contains a protein in the HPV outer shell. Once the anti-body attaches itself to an HPV protein it is marked for destruction. The vaccine only protects against HPV 6, 11 (causing warts) & 16, 18 ("causing" cancer).
The big problem is that it protects against an infection in the blood. But HPV is a tissue infection. Merck, the maker of Gardasil, and the FDA even warn on their websites that gardasil won't protect you against an infection you already have.
Well guess what? It offers very little to no protection against any tissue infection of HPV. Vaccines trigger Humoral Immune Response (HIR), antibodies in the blood. This type of response does very little to nothing for infections in tissue because antibodies cannot reach them. That is why Merck tells you Gardasil is useless if you are already infected.
Vaccines also trigger a local immune response in the tissue where they are injected. This type of response is called a Cell Mediated Immunity (CMI). CMI fights tissue infections caused by virus, bacteria and also fights cervical cancer (and many other cancers as well). But the CMI response in the injected muscle tissue does not spread anywhere else in your body, it stays right there in that muscle tissue and does not extend into the cervix!
Most people, when they get infected with HPV, clear the infection before any symptoms are noticed. Most people who develop symptoms like warts or dysplasia get rid of both without doctors, drugs or vaccines (dysplasia are abnormal cells in the cervix).
Peer-reviewed analysis and studies many of them on the FDA, NCI and CDC web sites point out the dangers of many of the vaccine ingredients including the potential for the HPV vaccines to increase the risk for pre-cancerous lesions if adolescents have been previously exposed to the human papillomavirus and then get vaccinated: 44.6% increase post Gardasil.
35 women aged 23.3±7.1 years participated in a study. Twenty-five had a high level of physical activity before vaccination and irregular periods were reported by all patients not on treatment with oral contraception. Serum bilirubin was below the lower detection limit in 17 patients. Twenty-one of the referred patients fulfilled the criteria for a diagnosis of POTS (60%, 95%CI 43-77%). All patients had orthostatic intolerance, 94% nausea, 82% chronic headache, 82% fatigue, 77% cognitive dysfunction, 72% segmental dystonia, 68% neuropathic pain.
In a population referred for symptoms of orthostatic intolerance and other symptoms consistent with autonomic dysfunction that began in close temporal association with a quadrivalent HPV vaccination, we identified a 60% prevalence of POTS. Further work is urgently needed to elucidate the potential for a causal link between the vaccine and circulatory abnormalities and to establish targeted treatment options for the affected patients.
Gardisil and Cervarix are useless, very expensive vaccines designed for profit, not to help people.